Strategies for the analysis of invitro radiation sensitivity and prediction of interaction with potential radiation modifying agents

International Journal of Radiation Biology

Volumn 86, Issue 6, 2010, Pages 458-466

  Luttjeboer, Mark ^a   Lafleur, M Vincent M ^b   Kwidama, Zinia J ^a   Rijn, Johannes Van ^b   Berg, Jaap Van Den ^b   Slotman, Ben J ^b   Kaspers, Gertjan J L ^a   Cloos, Jacqueline ^a  

^a Departments of Pediatric Oncology   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cell proliferation; Clonogenic survival; Combined modality treatment; Interaction analysis; Radiation sensitivity

Indexed keywords

CYTOSTATIC AGENT; RADIOSENSITIZING AGENT; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CELL LINE; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; IN VITRO STUDY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOSENSITIVITY; RAT; TUMOR CELL; ANIMAL; BIOLOGICAL MODEL; CELL SURVIVAL; DRUG EFFECT; DRUG SCREENING; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; RADIATION RESPONSE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COMBINED MODALITY THERAPY; CYTOSTATIC AGENTS; DOSE-RESPONSE RELATIONSHIP, RADIATION; MODELS, BIOLOGICAL; RADIATION TOLERANCE; RATS; TUMOR STEM CELL ASSAY;

EID: 77952499774     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553000903568019     Document Type: Article

References (16)

1. Chou TC, Talalay P. 1984. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation 22:27-55.
2. Courtenay VD, Mills J. 1978. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. British Journal of Cancer 37:261-268.
3. De Groot JF, Gilbert MR. 2007. New molecular targets in malignant gliomas. Current Opinions in Neurology 20:712-718.
4. Elkind MM, Sutton H. 1960. Radiation response of mammalian cells grown in culture. 1. Repair of X-ray damage in surviving Chinese hamster cells. Radiation Research 13:556-593.
5. Fan QW, Weiss WA. 2006. Isoform specific inhibitors of PI3 kinase in glioma. Cell Cycle 5:2301-2305.
6. Kuipers GK, Slotman BJ, Wedekind LE, Stoter TR, van den Berg J, Sminia P, Lafleur MV. 2007. Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration. International Journal of Radiation Biology 83:677-685.
7. Lam GK. 1989. Analysis of interaction for mixtures of agents using the linear isobole. Bulletin of Mathematical Biology 51:293-309.
8. Luttjeboer M, Kaspers GJK. 2006. Medulloblastoma: need for targeted treatment. Expert Review of Anticancer Therapy 6:649-652.
9. Neijenhuis S, Begg AC, Vens C. 2005. Radiosensitization by a dominant negative to DNA polymerase beta is DNA polymerase beta-independent and XRCC1-dependent. Radiotherapy and Oncology 76:123-128.
10. Puck TT, Marcus PI. 1956. Action of x-rays on mammalian cells. Journal of Experimental Medicine 103:653-666.
11. Reuber MD. 1961. A transplantable bile-secreting hepatocellular carcinoma in the rat. Journal of the National Cancer Institute 26:891-897.
12. Steel GG. 2002. Cell survival as a determinant of tumour response. In: G. G. Steel, editor. Basic clinical radiobiology, London: Arnold. pp 52-63.
13. Steel GG, Peckham MJ. 1979. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. International Journal of Radiation Oncology Biology and Physics 5:85-91.
14. Tubiana M, Courdi A. 1989. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival. Radiotherapy and Oncology 15:1-18.
15. van Rijn J, van den Berg J. 1997. Flavonoids as enhancers of x-rayinduced cell damage in hepatoma cells. Clinical Cancer Research 3:1775-1779.
16. Xu L, Yang D, Wang S, Tang W, Liu M, Davis M, Chen J, Rae JM, Lawrence T, Lippman ME. 2005. (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer. Molecular Cancer Therapeutics 4:197-205